Our approach to Sustainable Suppy Chain

As the Polpharma Group, being a provider of medicines and pharmaceutical ingredients, we recognise the importance of taking into account the environmental and social impact along the entire value chain of our business conduct.

At the same time, we are aware that comprehensive and lasting reduction of our negative impact on the environment, as well as taking responsibility for the influence in the social dimension, is only possible in close cooperation with those from whom we buy products and services – our suppliers. For this reason, a sustainable supply chain (SSC) has for years been an essential and integral part of our approach to responsible business operations.

We are gradually introducing new solutions and standards of working with our suppliers, while improving our own processes at the same time.

Sustainable Supply Chain Strategy

We strive to ensure that Polpharma Group's SSC efforts translate into a real change in awareness and performance of ESG (environmental, social, governance) standards among our suppliers. We are developing complementary Group solutions to support the purchasing process and selecting products and services with the least possible impact on the environment and communities.

As part of our ESG Strategy 2022-2025, we have developed dedicated solutions focused around improving our supply chain, which cover four priority areas:

  • ESG risk management in the supply chain – We are aware of the impact that not only economic risks, but also social and environmental risks can have on our operations at various points along the value chain. To prevent them from materialising, we carry out a cyclical assessment of ESG risks and their business impact in our supply chain. In addition, as part of our due diligence process, suppliers are regularly reviewed and classified enabling us to effectively prioritise our actions.
  • Verification of ESG expectations of suppliers – We take measures to ensure that our suppliers act in accordance with the standards we set. Every supplier who wishes to be included in the Polpharma Group’s value chain must familiarise themselves with the Polpharma Supplier Code of Conduct and sign an ethics clause (which is part of the general terms and conditions of the contract), thereby committing to comply with the provisions of the Code. In addition, we are working on a programme of ethical audits based on an internationally recognised methodology, which will apply to selected suppliers.
  • Reducing environmental footprint in the supply chain – We recognise the importance of the supply chain in our environmental impact. We measure and analyse our carbon footprint, including Scope 3 to identify the key purchasing categories with the highest contribution to it. Our plan is to create a programme to encourage suppliers to measure their carbon footprint and set environmental targets, providing them with the necessary tools and knowledge. Over the years, we have actively supported our suppliers in building awareness of major environmental challenges and priorities through dedicated training sessions, including in the area of the circular economy and carbon footprint.
  • Sustainable Supply Chain Management – We implement solutions to ensure high and unified standards related to supply chain and purchasing both inside and outside the organisation. Implemented in 2019, the Sustainable Supply Chain Policy is a key document that indicates the target state of our processes, guidelines and solutions used in building and maintaining supplier relationships. The document implies continuous improvement of the mechanisms put in place and their evaluation. The high level of our sustainable purchasing practices is confirmed by the ISO 20400 standard.

 

100%

of concluded contracts and orders include an ethics clause

170

number of representatives from our suppliers who attended ESG training sessions in 2023

630

number of self-evaluation questionnaires that were completed by our suppliers in the non-manufacturing category in 2023

Polpharma Supplier Code of Conduct

Aiming to maintain the highest standards, we expect suppliers to comply with requirements regarding ethical business practices, human and labour rights as well as environmental protection and climate action.

Our key guiding document for building and improving sustainable supply chain is the Polpharma Supplier Code of Conduct. The first version of the Code was drafted in 2015, the current version effective January 1, 2025. The Code refers to internationally recognised documents and standards such as the International Bill of Human Rights, the Paris Agreement and Agenda 2030, as well as European Union regulations such as the CSRD or the EU Taxonomy. It covers a range of ESG issues – environmental, social and corporate governance – to ensure the highest standards of business operations at our partners. We are committed to ensuring that our suppliers around the world conduct their business in accordance with the principles set out in the Code.

The principles described in the Polpharma Supplier Code of Conduct include:

Tackling corruption in all its forms
Prohibition on child labour
Respecting the principles of equality and tackling all forms of discrimination
Prohibition of slavery and forced labour
Reduction of environmental impact and preservation of natural resources
Ensuring safe and healthy working conditions
Protection of privacy and confidentiality of data
Ethical and responsible human and animal testing
Active contribution to the Sustainable Development Goals

Download the supplier code of conduct:

Educational support for suppliers

We ensure that the values we hold at Polpharma Group are respected and implemented in our supply chain. We believe that dialogue and collaboration with suppliers are key tools to achieve this. Our suppliers are offered a variety of educational activities - we have been running regular workshops on topical ESG issues since 2017.

So far, several hundred companies have already participated. We also involve suppliers in joint activities such as good practice competitions, the winners of which are rewarded with publication in our good practice guides. As well, we are keen to share Polpharma Group’s experience and good practices in sustainability.

Read also

We invite you to read the next articles on our website
stethoscope on the table

Ethics and Compliance

The Polpharma Group Ethics Program is the result of a discussion about goals, motives and "who we are and what we do". The premise of the Ethical Program is to maintain high standards in everyday work, both among colleagues from the company and external partners.
read more
Woman doing laboratory tests

Responsibility for product

Operating in the pharmaceutical industry, we accept our responsibilities for human health and life. That is why the quality of our products and the safety of patients are our priorities.
read more
Masurian landscape by Marek Wilczura

Environmental responsibility

We attach great importance to harmonious coexistence with the natural environment and we make efforts to minimise the environmental footprint of our manufacturing activities.
read more

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.